Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This randomized controlled unblinded trial aimes to compare BeFlared FEVAR Stent Graft System (BeFlared) with GORE® VIABAHN® VBX Balloon Expandable Endoprothesis (VBX) in patients undergoing endovascular aneurysm repair with fenestrated device (FEVAR).
Primary objectives:
Secondary objectives:
- compare intraoperative TV technical success in patients undergoing FEVAR with BeFlared and VBX bridging device.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BeFlared group | Active Comparator | Patients undergoing fenestrated endovascular aortic repair with BeFlared FEVAR Stent Graft System© |
|
| VBX group | Active Comparator | Patients undergoing fenestrated aortic repair with GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Randomization | Other | Preinterventional randomization of patients to one of two arms - fenestrated endovascular aortic repair with BeFlared FEVAR Stent Graft System© or GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis. |
| Measure | Description | Time Frame |
|---|---|---|
| Cumulative device time | Cumulative device time (measured in minutes) is defined as time between introduction of bridging stent graft (BSG) system into sheath and successful removal of deflated BSG flaring balloon for each of target vessels. | Intraoperative assessment during recruitment period of 2 years |
| Target vessel (TV) instability at follow-up | TV instability at early, short-term and midterm follow up - defined as any death or aneurysm rupture event related to TV complication (e.g. TV endoleak or rupture) or any secondary intervention indicated to treat a TV related complication, including TV endoleak, disconnection, kinking, stenosis, occlusion, or rupture. Early follow-up is defined as radiological and clinical follow-up of the patients within the first 30 postoperative days or withing the hospital stay if longer than 30 days. Short-term follow-up encompass follow-up between 30 days and 6 months. Midterm follow-up refer to follow-up that occur within 6 months to 5 years after FEVAR procedure. | Early follow-up of first patients enrolled - end of midterm follow-up of last patients enrolled |
| Measure | Description | Time Frame |
|---|---|---|
| Intraoperative target vessel (TV) success | Intraoperative target vessel (TV) technical success is defined as successful TV catheterization and placement of bridging stent graft (BSG) with restoration and maintenance of flow in all intended TVs. | Intraoperative assessment during recruitment period of 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Explorative objectives | Procedural metrics (operation time [minutes], dose of area product [Gy cm2], fluoroscopy time [minutes], dose of contrast agent applied [mL], intraoperative blood loss [mL]), duration of intensive care unit stay, TV patency, TV related endoleak formation, secondary TV related reinterventions as well as major adverse events (all-cause mortality, myocardial infarction, renal events, mesenteric events, respiratory events) at early, short-term and midterm postoperative outcome in patients undergoing FEVAR procedure with BeFlared or VBX bridging device will comprise explorative objectives (parameters) of this study. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wolf Hans Eilenberg, MD, PhD | Contact | +43 (0)1 40400-69560 | wolf.eilenberg@meduniwien.ac.at | |
| Anna Sotir, MD | Contact | anna.sotir@meduniwien.ac.at |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Vienna, Department of General Surgery, Division of Vascular Surgery | Recruiting | Vienna | State of Vienna | 1090 | Austria |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011897 | Random Allocation |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| First patient enrolled - last patient completing midterm follow-up |
| D008722 | Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |